| abstract |
Patent Summary: "Organic compound formulations". The present invention relates to solid pharmaceutical compositions comprising 4- (trifluoromethyl) -5- (2,6-dimorpholine pyrimidin-4-yl) pyridin-2-amine phosphatidyl inositol 3-kinase inhibitor or a pharmaceutically acceptable salt thereof. acceptable form thereof, sodium stearyl fumarate and optionally at least one additional pharmaceutically acceptable carrier. The present invention also relates to processes for preparing them and for using them as medicaments for treating cancer. |